Solomon J Lubinga

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 2

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Solomon J Lubinga, Lydia Walder, Mark Burton, Qin Shen
Budget impact of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a third-party US payer perspective. Journal of medical economics (2024)
Malin Berling, Mohammad A Chaudhary, Yong Yuan, Nebibe Varol, Peter Dale, Eleonora Testa, Johan Klint, Adam Lee, Solomon J Lubinga, John R Penrod
Cost-effectiveness analysis of nivolumab plus ipilimumab versus platinum-doublet chemotherapy for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States. Journal of medical economics 25 (1) (2022)